{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:16:25Z","timestamp":1787728585989,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81629-y","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:36:30Z","timestamp":1741865790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between TyG-BMI and BPH in a national prospective cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Bing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"81629_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/s0090-4295(94)80207-6","volume":"44","author":"FL Gu","year":"1994","unstructured":"Gu, F. L., Xia, T. L. & Kong, X. T. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China. Urology 44, 688\u2013691. https:\/\/doi.org\/10.1016\/s0090-4295(94)80207-6 (1994).","journal-title":"Urology"},{"key":"81629_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bju.15229","volume":"127","author":"CM Devlin","year":"2021","unstructured":"Devlin, C. M., Simms, M. S. & Maitland, N. J. Benign prostatic hyperplasia\u2014what do we know? BJU Int. 127, 389\u2013399. https:\/\/doi.org\/10.1111\/bju.15229 (2021).","journal-title":"BJU Int."},{"key":"81629_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s11934-996-0006-0","volume":"7","author":"DA Taub","year":"2006","unstructured":"Taub, D. A. & Wei, J. T. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr. Urol. Rep. 7, 272\u2013281. https:\/\/doi.org\/10.1007\/s11934-996-0006-0 (2006).","journal-title":"Curr. Urol. Rep."},{"key":"81629_CR4","doi-asserted-by":"publisher","first-page":"155798832110367","DOI":"10.1177\/15579883211036786","volume":"15","author":"XF Xu","year":"2021","unstructured":"Xu, X. F. et al. Global, regional, and national incidence and year lived with disability for benign prostatic hyperplasia from 1990 to 2019. Am. J. Mens Health 15, 15579883211036786. https:\/\/doi.org\/10.1177\/15579883211036786 (2021).","journal-title":"Am. J. Mens Health"},{"key":"81629_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11934-022-01091-z","volume":"23","author":"N Ottaiano","year":"2022","unstructured":"Ottaiano, N., Shelton, T., Sanekommu, G. & Benson, C. R. Surgical complications in the management of benign prostatic hyperplasia treatment. Curr. Urol. Rep. 23, 83\u201392. https:\/\/doi.org\/10.1007\/s11934-022-01091-z (2022).","journal-title":"Curr. Urol. Rep."},{"key":"81629_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","volume":"4","author":"KB Lim","year":"2017","unstructured":"Lim, K. B. Epidemiology of clinical benign prostatic hyperplasia. Asian J. Urol. 4, 148\u2013151. https:\/\/doi.org\/10.1016\/j.ajur.2017.06.004 (2017).","journal-title":"Asian J. Urol."},{"key":"81629_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11934-020-00985-0","volume":"21","author":"R Dornbier","year":"2020","unstructured":"Dornbier, R., Pahouja, G., Branch, J. & McVary, K. T. The New American Urological Association benign prostatic hyperplasia clinical guidelines: 2019 update. Curr. Urol. Rep. 21, 32. https:\/\/doi.org\/10.1007\/s11934-020-00985-0 (2020).","journal-title":"Curr. Urol. Rep."},{"key":"81629_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.eururo.2016.07.007","volume":"70","author":"M Gacci","year":"2016","unstructured":"Gacci, M. et al. Male lower urinary tract symptoms and cardiovascular events: a systematic review and meta-analysis. Eur. Urol. 70, 788\u2013796. https:\/\/doi.org\/10.1016\/j.eururo.2016.07.007 (2016).","journal-title":"Eur. Urol."},{"key":"81629_CR9","doi-asserted-by":"publisher","first-page":"38214","DOI":"10.1038\/srep38214","volume":"6","author":"MF Xia","year":"2016","unstructured":"Xia, M. F. et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci. Rep. 6, 38214. https:\/\/doi.org\/10.1038\/srep38214 (2016).","journal-title":"Sci. Rep."},{"key":"81629_CR10","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er, L. K. et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE 11, e0149731 (2016).","journal-title":"PLoS ONE"},{"key":"81629_CR11","doi-asserted-by":"publisher","first-page":"123192","DOI":"10.1016\/j.lfs.2024.123192","volume":"1","author":"X Fu","year":"2024","unstructured":"Fu, X., Wang, Y., Lu, Y., Liu, J. & Li, H. Association between metabolic syndrome and benign prostatic hyperplasia: the underlying molecular connection. Life Sci. 1, 123192 (2024).","journal-title":"Life Sci."},{"key":"81629_CR12","first-page":"205","volume":"1","author":"G Xu","year":"2024","unstructured":"Xu, G. et al. The etiology and pathogenesis of benign prostatic hyperplasia: the roles of sex hormones and anatomy. Res. Rep. Urol. 1, 205\u2013214 (2024).","journal-title":"Res. Rep. Urol."},{"key":"81629_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12062-011-9033-9","volume":"3","author":"J Strauss","year":"2010","unstructured":"Strauss, J. et al. Health outcomes and socio-economic status among the elderly in China: evidence from the CHARLS Pilot. J. Popul. Ageing 3, 111\u2013142 (2010).","journal-title":"J. Popul. Ageing"},{"key":"81629_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1086\/666952","volume":"61","author":"JP Smith","year":"2012","unstructured":"Smith, J. P., Shen, Y., Strauss, J., Zhe, Y. & Zhao, Y. The effects of childhood health on adult health and SES in China. Econ. Dev. Cult. Change 61, 127\u2013156 (2012).","journal-title":"Econ. Dev. Cult. Change"},{"key":"81629_CR15","first-page":"951","volume":"47","author":"X Lei","year":"2012","unstructured":"Lei, X., Hu, Y., McArdle, J. J., Smith, J. P. & Zhao, Y. Gender differences in cognition among older adults in China. J. Hum. Resour. 47, 951\u2013971 (2012).","journal-title":"J. Hum. Resour."},{"key":"81629_CR16","doi-asserted-by":"publisher","first-page":"1290639","DOI":"10.3389\/fendo.2023.1290639","volume":"14","author":"X Rao","year":"2023","unstructured":"Rao, X. et al. The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia. Front. Endocrinol. (Lausanne). 14, 1290639. https:\/\/doi.org\/10.3389\/fendo.2023.1290639 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"81629_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12967-022-03722-y","volume":"20","author":"YB Wang","year":"2022","unstructured":"Wang, Y. B. et al. Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study. J. Transl. Med. 20, 495. https:\/\/doi.org\/10.1186\/s12967-022-03722-y (2022).","journal-title":"J. Transl. Med."},{"key":"81629_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/joe-14-0283","volume":"222","author":"M Mraz","year":"2014","unstructured":"Mraz, M. & Haluzik, M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J. Endocrinol. 222, 113\u2013127. https:\/\/doi.org\/10.1530\/joe-14-0283 (2014).","journal-title":"J. Endocrinol."},{"key":"81629_CR19","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/jci21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa, S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 114, 1752\u20131761. https:\/\/doi.org\/10.1172\/jci21625 (2004).","journal-title":"J. Clin. Investig"},{"key":"81629_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.eururo.2007.06.038","volume":"52","author":"A Sciarra","year":"2007","unstructured":"Sciarra, A. et al. Inflammation and chronic prostatic diseases: evidence for a link? Eur. Urol. 52, 964\u2013972. https:\/\/doi.org\/10.1016\/j.eururo.2007.06.038 (2007).","journal-title":"Eur. Urol."},{"key":"81629_CR21","doi-asserted-by":"publisher","unstructured":"Corona, G. et al. Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int. J. Endocrinol. 329456. https:\/\/doi.org\/10.1155\/2014\/329456 (2014).","DOI":"10.1155\/2014\/329456"},{"key":"81629_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/luts.12420","volume":"14","author":"W Chen","year":"2022","unstructured":"Chen, W., Man, S., Wang, B., Kadeerhan, G. & Huang, X. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a cohort study of Chinese elderly males. Low Urin. Tract. Sympt. 14, 170\u2013177. https:\/\/doi.org\/10.1111\/luts.12420 (2022).","journal-title":"Low Urin. Tract. Sympt."},{"key":"81629_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.mce.2011.12.017","volume":"351","author":"G Williams","year":"2012","unstructured":"Williams, G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-\u03b1 and GPER signalling. Mol. Cell. Endocrinol. 351, 269\u2013278. https:\/\/doi.org\/10.1016\/j.mce.2011.12.017 (2012).","journal-title":"Mol. Cell. Endocrinol."},{"key":"81629_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.eururo.2014.10.016","volume":"67","author":"A Tubaro","year":"2015","unstructured":"Tubaro, A., De Nunzio, C., Puccini, F. & Presicce, F. The evolving picture of lower urinary tract symptom management. Eur. Urol. 67, 271\u2013272. https:\/\/doi.org\/10.1016\/j.eururo.2014.10.016 (2015).","journal-title":"Eur. Urol."},{"key":"81629_CR25","doi-asserted-by":"publisher","first-page":"e0301011","DOI":"10.1371\/journal.pone.0301011","volume":"19","author":"G Fan","year":"2024","unstructured":"Fan, G. et al. Untargeted metabolomics reveals that declined PE and PC in obesity may be associated with prostate hyperplasia. PLoS ONE 19, e0301011. https:\/\/doi.org\/10.1371\/journal.pone.0301011 (2024).","journal-title":"PLoS ONE"},{"key":"81629_CR26","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00345-023-04397-w","volume":"41","author":"J Lee","year":"2023","unstructured":"Lee, J. et al. Lowering the percent body fat in the obese population might reduce male lower urinary tract symptoms. World J. Urol. 41, 1621\u20131627. https:\/\/doi.org\/10.1007\/s00345-023-04397-w (2023).","journal-title":"World J. Urol."},{"key":"81629_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12894-023-01365-9","volume":"23","author":"M Daher","year":"2023","unstructured":"Daher, M., Saqer, T., Jabr, M. & Al-Mousa, S. Benign prostatic hyperplasia and metabolic syndrome; prevalence and association: a cross-sectional study in Syria. BMC Urol. 23, 187. https:\/\/doi.org\/10.1186\/s12894-023-01365-9 (2023).","journal-title":"BMC Urol."},{"key":"81629_CR28","doi-asserted-by":"publisher","first-page":"23667","DOI":"10.1038\/s41598-024-74737-2","volume":"14","author":"H Cao","year":"2024","unstructured":"Cao, H. et al. Association between circulating inflammatory proteins and benign prostatic disease: a Mendelian randomization study. Sci. Rep. 14, 23667 (2024).","journal-title":"Sci. Rep."},{"key":"81629_CR29","doi-asserted-by":"publisher","first-page":"139547","DOI":"10.1016\/j.molstruc.2024.139547","volume":"1320","author":"P Rana","year":"2025","unstructured":"Rana, P. et al. Unveiling the potential of novel 5\u03b1-reductase inhibitors via ligand based drug design, molecular docking and ADME predictions to manage BPH. J. Mol. Struct. 1320, 139547 (2025).","journal-title":"J. Mol. Struct."},{"key":"81629_CR30","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1080\/13685538.2020.1781806","volume":"23","author":"Y Xiong","year":"2020","unstructured":"Xiong, Y., Zhang, Y., Li, X., Qin, F. & Yuan, J. The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males. Aging Male 23, 1432\u20131439 (2020).","journal-title":"Aging Male"},{"key":"81629_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.prnil.2022.06.004","volume":"10","author":"Y Nagakura","year":"2022","unstructured":"Nagakura, Y., Hayashi, M. & Kajioka, S. Lifestyle habits to prevent the development of benign prostatic hyperplasia: analysis of Japanese nationwide datasets. Prostate Int. 10, 200\u2013206 (2022).","journal-title":"Prostate Int."},{"key":"81629_CR32","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/pros.24217","volume":"81","author":"G Liao","year":"2021","unstructured":"Liao, G. et al. Joint effect between bisphenol A and alcohol consumption on benign prostatic hyperplasia: a case\u2013control study in Hong Kong Chinese males. Prostate 81, 1214\u20131224 (2021).","journal-title":"Prostate"},{"key":"81629_CR33","first-page":"139","volume":"30","author":"LP Zeng","year":"2024","unstructured":"Zeng, L. P., Li, Y., Li, X. Y. & Yin, Z. Incidence of comorbid ED with LUTS and its risk factors in patients with BPH. Natl. J. Androl. 30, 139\u2013144 (2024).","journal-title":"Natl. J. Androl."},{"key":"81629_CR34","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1186\/s12889-023-15972-6","volume":"23","author":"K Ma","year":"2023","unstructured":"Ma, K. & Dong, Q. Association between sleep quality and benign prostate hyperplasia among middle-aged and older men in India. BMC Public Health 23, 1147 (2023).","journal-title":"BMC Public Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81629-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81629-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81629-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:36:32Z","timestamp":1741865792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81629-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["81629"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81629-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4746233\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8743"}}